Literature DB >> 16129686

Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors.

Alexander Beeser1, Zahara M Jaffer, Clemens Hofmann, Jonathan Chernoff.   

Abstract

The canonical extracellular-regulated kinase (ERK) signaling cascade, consisting of the Ras-Raf-Mek-ERK module, is critically important to many cellular functions. Although the general mechanism of activation of the ERK cascade is well established, additional noncanonical components greatly influence the activity of this pathway. Here, we focus on the group A p21-activated kinases (Paks), which have previously been implicated in regulating both c-Raf and Mek1 activity, by phosphorylating these proteins at Ser(338) and Ser(298), respectively. In NIH-3T3 cells, expression of an inhibitor of all three group A Paks reduced activation of ERK in response to platelet-derived growth factor (PDGF) but not to epidermal growth factor (EGF). Similar results were obtained in HeLa cells using small interference RNA-mediated simultaneous knockdown of both Pak1 and Pak2 to reduce group A Pak function. Inhibition of Pak kinase activity dramatically decreased phosphorylation of Mek1 at Ser(298) in response to either PDGF or EGF, but this inhibition did not prevent Mek1 activation by EGF, suggesting that although Pak can phosphorylate Mek1 at Ser(298), this event is not required for Mek1 activation by growth factors. Inhibition of Pak reduced the Ser(338) phosphorylation of c-Raf in response to both PDGF and EGF; however, in the case of EGF, the reduction in Ser(338) phosphorylation was not accompanied by a significant decrease in c-Raf activity. These findings suggest that Paks are required for the phosphorylation of c-Raf at Ser(338) in response to either growth factor, but that the mechanisms by which EGF and PDGF activate c-Raf are fundamentally different.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16129686     DOI: 10.1074/jbc.M502306200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  Phosphoinositides are essential coactivators for p21-activated kinase 1.

Authors:  Todd I Strochlic; Julien Viaud; Ulrike E E Rennefahrt; Theonie Anastassiadis; Jeffrey R Peterson
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

Review 2.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

3.  Profiling signaling polarity in chemotactic cells.

Authors:  Yingchun Wang; Shi-Jian Ding; Wei Wang; Jon M Jacobs; Wei-Jun Qian; Ronald J Moore; Feng Yang; David G Camp; Richard D Smith; Richard L Klemke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

4.  An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase.

Authors:  Sean W Deacon; Alexander Beeser; Jami A Fukui; Ulrike E E Rennefahrt; Cynthia Myers; Jonathan Chernoff; Jeffrey R Peterson
Journal:  Chem Biol       Date:  2008-04

5.  p21-activated kinase 1 (PAK1) can promote ERK activation in a kinase-independent manner.

Authors:  Zhipeng Wang; Meng Fu; Lifeng Wang; Juanjuan Liu; Yuhua Li; Cord Brakebusch; Qibing Mei
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

Review 6.  Cdc42 in oncogenic transformation, invasion, and tumorigenesis.

Authors:  Kristy Stengel; Yi Zheng
Journal:  Cell Signal       Date:  2011-04-16       Impact factor: 4.315

7.  Cadherins and Pak1 control contact inhibition of proliferation by Pak1-betaPIX-GIT complex-dependent regulation of cell-matrix signaling.

Authors:  Fengming Liu; Liwei Jia; Ann-Marie Thompson-Baine; Jason M Puglise; Martin B A Ter Beest; Mirjam M P Zegers
Journal:  Mol Cell Biol       Date:  2010-02-12       Impact factor: 4.272

8.  p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.

Authors:  Hoi Yee Chow; Dina Stepanova; Jennifer Koch; Jonathan Chernoff
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

9.  Tumor growth and angiogenesis is impaired in CIB1 knockout mice.

Authors:  Mohamed A Zayed; Weiping Yuan; Dan Chalothorn; James E Faber; Leslie V Parise
Journal:  J Angiogenes Res       Date:  2010-08-30

10.  Identification of MYO18A as a novel interacting partner of the PAK2/betaPIX/GIT1 complex and its potential function in modulating epithelial cell migration.

Authors:  Rae-Mann Hsu; Ming-Hung Tsai; Ya-Ju Hsieh; Ping-Chiang Lyu; Jau-Song Yu
Journal:  Mol Biol Cell       Date:  2009-11-18       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.